Fig. 1From: Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014–2018National estimates of mean annual healthcare costs (in millions) of pneumococcal disease in children aged < 18 years in the United States (2014–2018)Back to article page